504 related articles for article (PubMed ID: 12111488)
1. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
2. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
3. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G
Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
[TBL] [Abstract][Full Text] [Related]
4. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
5. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
[TBL] [Abstract][Full Text] [Related]
6. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery.
Partington MD; Davis DH; Laws ER; Scheithauer BW
J Neurosurg; 1994 Feb; 80(2):209-16. PubMed ID: 8283258
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic transsphenoidal treatment of hormonally active pituitary adenomas.
Rudnik A; Kos-Kudła B; Larysz D; Zawadzki T; Bazowski P
Neuro Endocrinol Lett; 2007 Aug; 28(4):438-44. PubMed ID: 17693972
[TBL] [Abstract][Full Text] [Related]
9. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
10. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
11. The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
Thomale UW; Stover JF; Unterberg AW
Zentralbl Neurochir; 2005 Aug; 66(3):126-32; discussion 132. PubMed ID: 16116555
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
14. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series.
Dehdashti AR; Ganna A; Karabatsou K; Gentili F
Neurosurgery; 2008 May; 62(5):1006-15; discussion 1015-7. PubMed ID: 18580798
[TBL] [Abstract][Full Text] [Related]
15. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
18. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
19. Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?
Lee EJ; Ahn JY; Noh T; Kim SH; Kim TS; Kim SH
Neurosurgery; 2009 Mar; 64(3 Suppl):ons62-9; discussion ons69-70. PubMed ID: 19240574
[TBL] [Abstract][Full Text] [Related]
20. [Trans-septo-sphenoidal operation for pituitary adenoma in 92 patients: results and follow-up endocrine studies].
Gasser RW; Spoendlin H; Finkenstedt G; Pallua AK; Aichner F; Braunsteiner H
Wien Klin Wochenschr; 1993; 105(7):204-7. PubMed ID: 8385381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
